These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38835234)

  • 1. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy.
    Yang N; Yun WJ; Cui ZG; Zheng HC
    J Obstet Gynaecol; 2024 Dec; 44(1):2347430. PubMed ID: 38835234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic roles of GPR176 in breast cancer: a potential marker of aggressiveness and a potential target of gene therapy.
    Yun WJ; Xue H; Yang N; Xiao LJ; Sun HZ; Zheng HC
    Clin Transl Oncol; 2023 Oct; 25(10):3042-3056. PubMed ID: 37079213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promoting effects of GPR176 expression on proliferation, chemoresistance, lipogenesis and invasion of oesophageal cancer.
    Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14641-14655. PubMed ID: 37584712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of GPR176 predicts poor prognosis of gastric cancer patients and promotes the proliferation, migration, and invasion of gastric cancer cells.
    Zhang Y; Gu X; Zhu F; Li Y; Huang Y; Ju S
    Sci Rep; 2023 Jun; 13(1):9360. PubMed ID: 37291181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioinformatics analysis of the clinicopathological and prognostic significance of
    Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
    J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 7. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
    Wu Y; Zhu B; Yan Y; Bai S; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Mol Oncol; 2021 May; 15(5):1584-1596. PubMed ID: 33641229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
    Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
    Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA‑199b‑3p suppresses growth and progression of ovarian cancer via the CHK1/E‑cadherin/EMT signaling pathway by targeting ZEB1.
    Wei L; He Y; Bi S; Li X; Zhang J; Zhang S
    Oncol Rep; 2021 Feb; 45(2):569-581. PubMed ID: 33416170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer.
    Wang X; Zhao S; Guo Y; Wang C; Han S; Wang X
    J Obstet Gynaecol; 2024 Dec; 44(1):2363515. PubMed ID: 38864487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
    Zhang J; Guan W; Xu X; Wang F; Li X; Xu G
    Oncogene; 2021 Jul; 40(30):4906-4918. PubMed ID: 34163033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
    Zhang CY; Zhang L; Wang ZM; Ren DH; Zheng HC
    J Obstet Gynaecol; 2023 Dec; 43(1):2213764. PubMed ID: 37218920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor ZEB1 mediates the progression of epithelial ovarian cancer by promoting the transcription of CircANKRD17.
    Cai W; Zhang Q
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23086. PubMed ID: 35521974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
    Chen XJ; An N
    J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.
    Wang Y; Sheng Q; Spillman MA; Behbakht K; Gu H
    Oncogene; 2012 May; 31(20):2512-20. PubMed ID: 21996746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.